Suppression of HIF-1α expression and radiation resistance in acute hypoxic conditions

Oike,Takahiro; Suzuki,Yoshiyuki; Al-Jahdari,Wael; Mobaraki,Abdulelah; Saitoh,Jun‑Ichi; Torikai,Kohta; Shirai,Katsuyuki; Nakano,Takashi

doi:10.3892/etm.2011.373

Suppression of HIF-1α expression and radiation resistance in acute hypoxic conditions

Authors:
- Takahiro Oike
- Yoshiyuki Suzuki
- Wael Al-Jahdari
- Abdulelah Mobaraki
- Jun‑Ichi Saitoh
- Kohta Torikai
- Katsuyuki Shirai
- Takashi Nakano
View Affiliations

Affiliations: Department of Radiation Oncology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan, Gunma University Heavy Iron Medical Center, Gunma 371-8511, Japan
Published online on: October 21, 2011 https://doi.org/10.3892/etm.2011.373
Pages: 141-145

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Recently, it has become clear that acute hypoxia affecting radioresistance exists widely in tumor tissues. Concurrently, hypoxia-inducible factor-1α (HIF-1α) is recognized as an essential transcriptional factor, enabling cells to survive through hypoxia. However, it is unclear as to whether HIF-1α plays a direct role in the radioresistance caused by acute hypoxia. Therefore, in this study, we investigated the in vitro response of the human lung adenocarcinoma cell line, A549, to ionizing radiation in an experimental model that imitates acute hypoxia in the presence and absence of HIF-1α expression, using the HIF-1α inhibitor 5-[1‑(phenylmethyl)‑1H‑indazol‑3-yl]‑2-furanmethanol (YC-1). Cells were treated with or without 10 µM YC-1 for 2 h. Cells were exposed to either 95% N2 and 5% CO2 (hypoxic condition of <0.1 mmHg) or atmospheric air (normoxic condition) for 1 h, and irradiated with 2, 5 and 10 Gy. Western blot analysis revealed that, without YC-1, cells exposed to hypoxic conditions expressed increased levels of HIF-1α compared with those exposed to normoxic conditions. Under hypoxic conditions, HIF-1α expression was suppressed by YC-1 to the same extent as that observed in cells exposed to normoxic conditions without YC-1. Clonogenic survival assay revealed that under hypoxic conditions there was no significant difference between the surviving fraction of cells treated with YC-1 and without YC-1 at any dose point examined. The oxygen enhancement ratio at 10% surviving fraction was calculated as 2.7 and 2.6 in the presence and the absence of YC-1, respectively. These results indicate that HIF-1α itself is not an immediate cause of acute hypoxia-induced radioresistance in A549 cells.

View Figures

View References

1.	JM BrownWR WilsonExploiting tumour hypoxia in cancer treatmentNat Rev Cancer4437447200410.1038/nrc1367
2.	RA GatenbyHB KesslerJS RosenblumLR CoiaPJ MoldofskyWH HartzOxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapyInt J Radiat Oncol Biol Phys14831838198810.1016/0360-3016(88)90002-83360652
3.	RF KallmanThe phenomenon of reoxygenation and its implications for fractionated radiotherapyRadiology105135412197210.1148/105.1.1354506641
4.	M NordsmarkM OvergaardJ OvergaardPretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neckRadiother Oncol413139199610.1016/S0167-8140(96)91811-38961365
5.	P VaupelK SchlengerC KnoopM HöckelOxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O₂ tension measurementsCancer Res5133162219912040005
6.	KA YehS BiadeRM LancianoDQ BrownMC FenningJS BabbPolarographic needle electrode measurements of oxygen in rat prostate carcinomasInt J Radiat Oncol Biol Phys33111118199510.1016/0360-3016(95)00036-X7642408
7.	Y SuzukiT NakanoT OhnoS KatoY NiibeS MoritaOxygenated and reoxygenated tumors show better local control in radiation therapy for cervical cancerInt J Gynecol Cancer16306311200610.1111/j.1525-1438.2006.00341.x16445650
8.	EJ HallAJ GiacciaOxygen effect and reoxygenationRadiobiology for the RadiologistL McAllister6th editionLippincott Williams & WilkinsPhiladelphia, PA851052006
9.	RK JainNormalization of tumor vasculature: an emerging concept in antiangiogenic therapyScience3075862200510.1126/science.110481915637262
10.	MJ TrotterDJ ChaplinRE DurandPL OliveThe use of fluorescent probes to identify regions of transient perfusion in murine tumorsInt J Radiat Oncol Biol Phys16931934198910.1016/0360-3016(89)90889-42703399
11.	I TuftoEK RofstadTransient perfusion in human melanoma xenograftsBr J Cancer71789793199510.1038/bjc.1995.1537536022
12.	LI Cárdenas-NaviaD MaceRA RichardsonDF WilsonS ShanMW DewhirstThe pervasive presence of fluctuating oxygenation in tumorsCancer Res6858125819200818632635
13.	MC Brahimi-HornJ PouysségurHIF at a glanceJ Cell Sci12210551057200910.1242/jcs.03502219339544
14.	EB RankinAJ GiacciaThe role of hypoxia-inducible factors in tumorigenesisCell Death Differ15678685200810.1038/cdd.2008.2118259193
15.	LE HuangZ AranyDM LivingstonHF BunnActivation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunitJ Biol Chem2713225332259199610.1074/jbc.271.50.32253
16.	T HoferI DesbailletsG HöpflM GassmannRH WengerDissecting hypoxia-dependent and hypoxia-independent steps in the HIF-1 alpha activation cascade: implications for HIF-1 alpha gene therapyFASEB J1527152717200111606485
17.	D ChilovG CamenischI KvietikovaU ZieglerM GassmannRH WengerInduction and nuclear translocation of hypoxia- inducible factor-1 (HIF-1): heterodimerization with ARNT is not necessary for nuclear accumulation of HIF-1alphaJ Cell Sci11212031212199910085255
18.	GL SemenzaHypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasisJ Lab Clin Med131207214199810.1016/S0022-2143(98)90091-99523843
19.	L XueguanW XiaoshenZ YongshengH ChaosuS ChunyingF YanHypoxia inducible factor-1alpha and vascular endothelial growth factor expression are associated with a poor prognosis in patients with nasopharyngeal carcinoma receiving radiotherapy with carbogen and nicotinamideClin Oncol20606612200810.1016/j.clon.2008.07.001
20.	DM AebersoldP BurriKT BeerJ LaissueV DjonovRH GreinerExpression of hypoxia-inducible factor-1 alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancerCancer Res6129112916200111306467
21.	R BosH ZhongCF HanrahanEC MommersGL SemenzaHM PinedoLevels of hypoxia-inducible factor-1 alpha during breast carcinogenesisJ Natl Cancer Inst93309314200110.1093/jnci/93.4.30911181778
22.	P BirnerM SchindlA ObermairC PlankG BreiteneckerG OberhuberOverexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancerCancer Res6046934696200010987269
23.	P BirnerB GatterbauerG OberhuberM SchindlK RösslerA ProdingerExpression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: Its impact on prognosis and on neoangiogenesisCancer92165171200110.1002/1097-0142(20010701)92:1%3C165::AID-CNCR1305%3E3.0.CO;2-F11443623
24.	Y FurusawaK FukutsuM AokiH ItsukaichiK Eguchi-KasaiH OharaInactivation of aerobic and hypoxic cells from three different cell lines by accelerated (3)He-, (12)C- and (20)Ne-ion beamsRadiat Res154485496200010.1667/0033-7587(2000)154%5B0485:IOAAHC%5D2.0.CO;211025645
25.	D VordermarkA KatzerK BaierP KraftM FlentjeCell type-specific association of hypoxia-inducible factor-1 alpha (HIF-1 alpha) protein accumulation and radiobiologic tumor hypoxiaInt J Radiat Oncol Biol Phys5812421250200410.1016/j.ijrobp.2003.11.03015001269
26.	ND ArvoldN GuhaD WangM MatliDF DeenRS WarrenHypoxia-induced radioresistance is independent of hypoxia-inducible factor-1 in vitroInt J Radiat Oncol Biol Phys62207212200510.1016/j.ijrobp.2005.01.01915850923
27.	A StaabJ LoefflerHM SaidD DiehlmannA KatzerM BeyerEffects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cellsBMC Cancer7213220200710.1186/1471-2407-7-21317999771
28.	H HaradaS Kizaka-KondohS ItasakaK ShibuyaA MorinibuK ShinomiyaThe combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenograftsBiochem Biophys Res Commun360791796200710.1016/j.bbrc.2007.06.14917624305